Polen Capital, an investment management company, released its “Polen Global Growth Strategy” fourth-quarter 2024 investor ...

The company leverages therapeutic expertise and economies of scale to provide value to pharmaceutical and biotech clients.

We came across a bullish thesis on ICON Public Limited Company (ICLR) on Substack by Oliver | MMMT Wealth. In this article, ...

The cyclical, high-risk, high-reward nature of the biotech industry is on full display in 2024. This industry is centered on using living organisms and bioprocesses for innovative drug development ...

China’s DeepSeek shocked the world by delivering unexpected innovation at an unbelievable price. But this disruptive trend isn’t confined to Big Tech: It has been quietly happening in the ...

The biotech market is experiencing cautious capital allocation, with decision-making and trial start speeds not yet normalized. Icon PLC (NASDAQ:ICLR) anticipates that pass-through revenue mix ...